BioCentury | Jan 14, 2021
Regulation

After pushing FDA out of and back into COVID-19 LDT review, HHS turns to outsourcing

...for EUA reviews.The consulting and CDO firm NDA Partners, a subsidiary of The Planet Group (TPG...
...lead on review of serology tests for antibodies against SARS-CoV-2.NDA Partners, in collaboration with fellow TPG...
BioCentury | Jan 8, 2021
Deals

Jan. 7 Quick Takes: Strong demand for Cullinan IPO; plus Bayer-CureVac COVID deal and venture rounds for Scorpion, Kira, Carisma and Abcuro and more

...Ventures and Livzon Pharmaceutical Group Inc. Existing investors AbbVie Ventures, HealthCap, Wellington Partners, IP Group, TPG...
...Capital Management Vivo Capital Foresite Capital Qiming Venture Partners Carisma Therapeutics Inc. SymBiosis LLC Solasta Ventures Livzon Pharmaceutical Group Inc. AbbVie Ventures HealthCap Wellington Partners IP Group TPG...
BioCentury | Jan 6, 2021
Management Tracks

Lin leaving Nektar as CMO; plus HKEX’s Tai named interim CEO, PureTech, Patient Square Capital, Novacyt and more

...as a founding partner and general counsel. Fliss was the general counsel of TPG Capital, TPG’s...
BioCentury | Oct 26, 2020
Deals

Bayer’s $2B deal for AskBio follows biotech’s decision to bet on its own pipeline

...April 2019, AskBio raised $225 million from TPG...
BioCentury | Oct 24, 2020
Finance

Oct. 23 Quick Takes: RA Capital’s $461M new fund; plus venture rounds for Sirnaomics, 3D Medicines, Zhaoke, Orbus, Araris

...HKEX:950) raised $145 million in a series B financing round jointly led by Hillhouse COFL, TPG...
BioCentury | Oct 23, 2020
Product Development

Fresh $20M allows Azura to move lead candidate into pivotal testing for major cause of dry eye

...cause of dry eye syndrome.Azura Ophthalmics Ltd. received the funding from current shareholders OrbiMed Advisors, TPG...
BioCentury | Sep 15, 2020
Finance

Cell therapy play Neogene’s $110M series A marks first investment for Tordjman’s Jeito Capital

...LSE:SYNC) with participation from Polaris Partners and Pontifax as well as seed investors Vida Ventures, TPG...
BioCentury | Jun 26, 2020
Finance

Akouos’ first-day pop outshines peers among NASDAQ IPO trio

...Street Partners, Varian Medical Systems, Johnson & Johnson (NYSE:JNJ), the Canada Pension Plan Investment Board, TPG...
BioCentury | Jun 9, 2020
Finance

Regeneron joins $100M round for DNAnexus to support global growth

...by new investor Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and existing investors GV, Foresite Capital Management LLC, TPG...
...company Almac Group Ltd. Danielle Kopke, Staff Writer DNAnexus Inc. Perceptive Advisors Northpond Ventures LLC Regeneron Pharmaceuticals Inc. GV Foresite Capital Management, LLC TPG...
BioCentury | May 28, 2020
Finance

May 27 Quick Takes: Atara raises $176M on back of MS data; plus Exscientia’s $60M C round, Geron, Silence, Arvelle, ViaCyte, Poxel, Accure, Tollys

...in the round so far to about $50 million. Existing investors Bain Capital Life Sciences, TPG...
Items per page:
1 - 10 of 279
BioCentury | Jan 14, 2021
Regulation

After pushing FDA out of and back into COVID-19 LDT review, HHS turns to outsourcing

...for EUA reviews.The consulting and CDO firm NDA Partners, a subsidiary of The Planet Group (TPG...
...lead on review of serology tests for antibodies against SARS-CoV-2.NDA Partners, in collaboration with fellow TPG...
BioCentury | Jan 8, 2021
Deals

Jan. 7 Quick Takes: Strong demand for Cullinan IPO; plus Bayer-CureVac COVID deal and venture rounds for Scorpion, Kira, Carisma and Abcuro and more

...Ventures and Livzon Pharmaceutical Group Inc. Existing investors AbbVie Ventures, HealthCap, Wellington Partners, IP Group, TPG...
...Capital Management Vivo Capital Foresite Capital Qiming Venture Partners Carisma Therapeutics Inc. SymBiosis LLC Solasta Ventures Livzon Pharmaceutical Group Inc. AbbVie Ventures HealthCap Wellington Partners IP Group TPG...
BioCentury | Jan 6, 2021
Management Tracks

Lin leaving Nektar as CMO; plus HKEX’s Tai named interim CEO, PureTech, Patient Square Capital, Novacyt and more

...as a founding partner and general counsel. Fliss was the general counsel of TPG Capital, TPG’s...
BioCentury | Oct 26, 2020
Deals

Bayer’s $2B deal for AskBio follows biotech’s decision to bet on its own pipeline

...April 2019, AskBio raised $225 million from TPG...
BioCentury | Oct 24, 2020
Finance

Oct. 23 Quick Takes: RA Capital’s $461M new fund; plus venture rounds for Sirnaomics, 3D Medicines, Zhaoke, Orbus, Araris

...HKEX:950) raised $145 million in a series B financing round jointly led by Hillhouse COFL, TPG...
BioCentury | Oct 23, 2020
Product Development

Fresh $20M allows Azura to move lead candidate into pivotal testing for major cause of dry eye

...cause of dry eye syndrome.Azura Ophthalmics Ltd. received the funding from current shareholders OrbiMed Advisors, TPG...
BioCentury | Sep 15, 2020
Finance

Cell therapy play Neogene’s $110M series A marks first investment for Tordjman’s Jeito Capital

...LSE:SYNC) with participation from Polaris Partners and Pontifax as well as seed investors Vida Ventures, TPG...
BioCentury | Jun 26, 2020
Finance

Akouos’ first-day pop outshines peers among NASDAQ IPO trio

...Street Partners, Varian Medical Systems, Johnson & Johnson (NYSE:JNJ), the Canada Pension Plan Investment Board, TPG...
BioCentury | Jun 9, 2020
Finance

Regeneron joins $100M round for DNAnexus to support global growth

...by new investor Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and existing investors GV, Foresite Capital Management LLC, TPG...
...company Almac Group Ltd. Danielle Kopke, Staff Writer DNAnexus Inc. Perceptive Advisors Northpond Ventures LLC Regeneron Pharmaceuticals Inc. GV Foresite Capital Management, LLC TPG...
BioCentury | May 28, 2020
Finance

May 27 Quick Takes: Atara raises $176M on back of MS data; plus Exscientia’s $60M C round, Geron, Silence, Arvelle, ViaCyte, Poxel, Accure, Tollys

...in the round so far to about $50 million. Existing investors Bain Capital Life Sciences, TPG...
Items per page:
1 - 10 of 279